Literature DB >> 1016830

Inverted papilloma of the lower urinary tract.

K M Cameron, C H Lupton.   

Abstract

A study of 35 cases of inverted papilloma of urothelium confirms that it is a distinctive entity and typically benign. These lesions occur mainly in males, may be multiple, and are sometimes situated elsewhere than in or near the trigone, which is their characteristic site. Their precise histogenesis remains uncertain. It must be stressed that not all transitional cell tumours of inverted pattern are of this type; some will have the appearance of and behave as malignant tumours. The same diagnostic criteria of malignancy established for the more common exophytic papillary neoplasms must be applied also to the inverted papillary tumours herein described.

Entities:  

Mesh:

Year:  1976        PMID: 1016830     DOI: 10.1111/j.1464-410x.1976.tb06703.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

Review 1.  The nested variant of the transitional cell bladder carcinoma: a case report and review of the literature.

Authors:  B H Ozdemir; G Ozdemir; A Sertçelik
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

2.  A case of inverted papilloma of the ureter: is the DNA ploidy pattern associated with occurrence of transitional cell carcinoma of the bladder?

Authors:  K Kunimi; T Uchibayashi; M Egawa
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

3.  Immunohistochemistry and Fluorescence In Situ Hybridization Can Inform the Differential Diagnosis of Low-Grade Noninvasive Urothelial Carcinoma with an Inverted Growth Pattern and Inverted Urothelial Papilloma.

Authors:  Juan-Juan Sun; Yong Wu; Yong-Ming Lu; Hui-Zhi Zhang; Tao Wang; Xiao-Qun Yang; Meng-Hong Sun; Chao-Fu Wang
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

4.  Inverted urothelial papilloma of the upper urinary tract: description of two cases with systematic literature review.

Authors:  R Santi; I C Galli; V Canzonieri; J I Lopez; G Nesi
Journal:  Diagn Pathol       Date:  2020-04-22       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.